Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Abbott Laboratories publishes a filing, an earnings call transcript or a press release.

Get ABT alerts

About Philip P. Boudreau

Philip P. Boudreau is recorded as CFO at Abbott Laboratories (ABT) since September 1, 2023. Abbott Laboratories reported in an 8-K filed June 12, 2023 that Philip P. Boudreau was appointed Senior Vice President, Finance and Chief Financial Officer, effective September 1, 2023. The proxy statement of Abbott Laboratories reports total compensation of $9,090,636 for Philip P. Boudreau in fiscal 2025, including a base salary of $974,231. Disclosed compensation is on record for 3 fiscal years. Abbott Laboratories is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Abbott Laboratories includes Robert B. Ford (CEO, Chairman and Board Member), Robert E. Funck, Jr. (CFO), Claire Babineaux-Fontenot (Board Member) and 7 others.

“Philip P. Boudreau has been appointed Senior Vice President, Finance and Chief Financial Officer and will continue to report to Mr. Funck in his new role”
Abbott Laboratories Form 8-K, filed June 12, 2023 · Read the filing

Affiliation history

Company network

Leadership on record at Abbott Laboratories

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Abbott Laboratories (ABT) $974,231 $9,090,636
2024 Abbott Laboratories (ABT) $884,039 $8,225,746
2023 Abbott Laboratories (ABT) $513,943 $3,317,182

Recent activity